ProCE Banner Activity

Research Focus: Targeting CEACAM5 With Novel Antibody-Drug Conjugates in Nonsquamous Non-Small-Cell-Lung Cancer

Slideset

Downloadable slideset reviewing biomarker testing in advanced nonsquamous NSCLC, including CEACAM5 and the potential role of emerging antibody-drug conjugates targeting this biomarker.

Released: June 09, 2023

Share

Faculty

David Planchard

David Planchard, MD, PhD

Head of Thoracic Cancer Group
Department of Medical Oncology
Gustave Roussy
Paris-Saclay University
International Center for Thoracic Cancers
Villejuif, France

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi